ERBB2 and breast carcinoma: After 4 years of stable disease, thoraco-abdominopelvic computed tomography scan showed lung progression with pulmonary biopsy consistent with breast carcinoma hormone receptor-positive and strong positivity for HER2, reviewed by two different pathologists, and confirmed by fluorescent in situ hybridization (Fig. 1).